Related Experiment Video
Updated: Dec 25, 2025

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle
Published on: June 8, 2022
Cardiac Alterations in Patients with Familial Lipodystrophy
Minna Moreira Dias Romano1, Paula Ananda Inês Chacon1, Fernanda Naira Zambelli Ramalho1
1Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto - Medicina Interna, Ribeirão Preto, SP - Brazil.
None:
Familial lipodystrophy is a rare genetic condition in which individuals have, besides metabolic changes and body fat deposits, a type of cardiomyopathy that has not been well studied. Many of the patients develop cardiovascular changes, the most commonly reported in the literature being the expression of a type of hypertrophic cardiomyopathy. This article, presented as a bibliographic review, reviews the clinical and cardiovascular imaging aspects in this scenario of cardiomyopathy in a rare metabolic disease, based on the latest scientific evidence published in the area. Despite the frequent association of congenital lipodystrophy and ventricular hypertrophy described in the literature, the pathophysiological mechanisms of this cardiomyopathy have not yet been definitively elucidated, and new information on cardiac morphological aspects is emerging in the aegis of recent and advanced imaging methods, such as cardiac magnetic resonance.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease I: Introduction

